-
公开(公告)号：US08741369B2
公开(公告)日：2014-06-03
申请号：US11085696
申请日：2005-03-21
申请人： Keith E. Petrofsky , Steven P. Greiner , Amy L. Matusheski , Uraiwan Tangprasertchai , Samira Mirarefi
发明人： Keith E. Petrofsky , Steven P. Greiner , Amy L. Matusheski , Uraiwan Tangprasertchai , Samira Mirarefi
IPC分类号： A21D10/00
CPC分类号： A21D8/06 , A21D2/16 , A21D2/183 , A21D2/185 , A21D2/186 , A21D2/188 , A21D2/32 , A21D2/36 , A21D13/41
摘要： Microwavable dough compositions are provided that are effective for providing products with improved texture using microwave heating. More specifically, the microwavable dough compositions include a blend of fiber, hydrocolloid, methylcellulose and functional surfactants in amounts that are effective for providing a cooked dough having improved firmness for an extended time after microwave cooking.
摘要翻译： 提供可微波面团组合物，其有效用于使用微波加热提供具有改善质地的产品。 更具体地说，微波炉生面团组合物包括纤维，水胶体，甲基纤维素和功能性表面活性剂的混合物，其量可以有效地提供在微波烹饪之后延长时间具有改进的坚固度的熟面团。
-
公开(公告)号：US08568773B2
公开(公告)日：2013-10-29
申请号：US12934338
申请日：2009-06-24
申请人： Gai Ben Dror , Dorit Platt , Orly Farkash , Rassan Zuabi , Zohar Bar-On , Avidor Shulman , Dori Pelled , Yael Richter
发明人： Gai Ben Dror , Dorit Platt , Orly Farkash , Rassan Zuabi , Zohar Bar-On , Avidor Shulman , Dori Pelled , Yael Richter
CPC分类号： A61K47/544 , A21D2/32 , A23D7/013 , A23D9/013 , A23L33/12 , A23L33/30 , A23L33/40 , A23V2002/00 , A61K31/201 , A61K31/202 , A61K31/66 , A61K31/685 , C07F9/10 , A23V2200/322 , A23V2250/1882 , A23V2250/1942 , A23V2250/1842
摘要： The invention described herein provides a preparation comprising a non-mammalian derived mixture of serine glycerophospholipid conjugates with a specific content and specific conjugation patterns of LA, linolenic acid (alpha-linolenic acid, gamma-linolenic acid) DHA and EPA which depend on utilizing different sources of lipids, and uses of such preparations.
-
3.发明授权Glycerophospholipids containing omega-3 and omega-6 fatty acids and their use in the treatment and improvement of cognitive functions 有权含有ω-3和ω-6脂肪酸的甘油磷脂及其在治疗和改善认知功能中的应用公开(公告)号：US08052992B2
公开(公告)日：2011-11-08
申请号：US11414150
申请日：2006-04-28
申请人： Gai Ben Dror , Dorit Plat , Orly Farkash , Rassan Zuabi , Zohar Bar-On , Avidor Shulman , Dori Pelled
发明人： Gai Ben Dror , Dorit Plat , Orly Farkash , Rassan Zuabi , Zohar Bar-On , Avidor Shulman , Dori Pelled
CPC分类号： A21D2/32 , A23D7/011 , A23D7/013 , A23D9/013 , A23K20/158 , A23L33/12 , A23V2002/00 , A61K31/685 , C07F9/106 , A23V2200/322 , A23V2250/1882 , A23V2250/1942 , A23V2250/1842
摘要： Disclosed herein is a lipid preparation, said preparation comprising a phosphatidylserine moiety, and poly-unsaturated fatty acid (PUFA) acyl groups, particularly long-chain poly-unsaturated fatty acid (LC-PUFA) acyl groups such as omega-3 and/or omega-6 acyl groups, wherein said PUFA is covalently bound to said glycerophospholipid. Said lipid preparations are particularly useful in the treatment of mental and cognitive disorders, e.g. ADHD (attention deficit hyperactivity disorder) and Alzheimer's disease.The disclosed preparations present improved bioactivity, and are useful in the treatment of various cognitive and mental conditions and disorders, as well as for maintenance of normal functions of brain-related systems and processes.
摘要翻译： 本文公开了一种脂质制剂，所述制剂包含磷脂酰丝氨酸部分和多不饱和脂肪酸（PUFA）酰基，特别是长链多不饱和脂肪酸（LC-PUFA）酰基，例如ω-3和/或 ω-6酰基，其中所述PUFA与所述甘油磷脂共价结合。 所述脂质制剂特别可用于治疗精神和认知障碍，例如， ADHD（注意缺陷多动障碍）和阿尔茨海默病。 所公开的制剂提供了改善的生物活性，并且可用于治疗各种认知和精神状况和障碍，以及维持脑相关系统和过程的正常功能。
-
公开(公告)号：US07935365B2
公开(公告)日：2011-05-03
申请号：US12215080
申请日：2008-06-24
申请人： Gai Ben Dror , Dorit Platt , Orly Farkash , Rassan Zuabi , Zohar Bar-On , Avidor Shulman , Dori Pelled , Yael Richter
发明人： Gai Ben Dror , Dorit Platt , Orly Farkash , Rassan Zuabi , Zohar Bar-On , Avidor Shulman , Dori Pelled , Yael Richter
CPC分类号： A61K47/544 , A21D2/32 , A23D7/013 , A23D9/013 , A23L33/12 , A23L33/30 , A23L33/40 , A23V2002/00 , A61K31/201 , A61K31/202 , A61K31/66 , A61K31/685 , C07F9/10 , A23V2200/322 , A23V2250/1882 , A23V2250/1942 , A23V2250/1842
摘要： This invention provides a preparation comprising serine glycerophospholipids which comprise a mixture of serine glycerophospholipids comprising eicosapentaenoic acid (EPA) and serine glycerophospholipids comprising docosahexaenoic acid (DHA), wherein each such serine glycerophospholipid comprising EPA and each such serine glycerophospholipid comprising DHA has the formula (I): wherein R″ is serine; wherein one of R or R′ is acyl EPA or acyl DHA and the other of R or R′ is hydrogen or an acyl group; wherein the combined amount of EPA and DHA present in such mixture of serine glycerophospholipids constitutes 10-50% by weight of the total fatty acids content of the serine glycerophospholipids in said preparation; and wherein the mixture is not identical to naturally occurring human or mammalian brain PS.
摘要翻译： 本发明提供包含丝氨酸甘油磷脂的制剂，其包含二十碳五烯酸（EPA）和包含二十二碳六烯酸（DHA）的丝氨酸甘油磷脂的丝氨酸甘油磷脂的混合物，其中每个这样的包含EPA的丝氨酸甘油磷脂和每种这样的包含DHA的丝氨酸甘油磷脂具有式 ）：其中R“为丝氨酸; 其中R或R'之一为酰基EPA或酰基DHA，R或R'中的另一个为氢或酰基; 其中存在于丝氨酸甘油磷脂的这种混合物中的EPA和DHA的组合量构成所述制剂中丝氨酸甘油磷脂的总脂肪酸含量的10-50重量％ 并且其中所述混合物与天然存在的人或哺乳动物脑PS不相同。
-
公开(公告)号：US20100068293A1
公开(公告)日：2010-03-18
申请号：US12306621
申请日：2007-07-13
申请人： Daniel Dalemans , Christophe Blecker , Pascal Bodson , Sabine Danthine , Claude Deroanne , Michel Paquot
发明人： Daniel Dalemans , Christophe Blecker , Pascal Bodson , Sabine Danthine , Claude Deroanne , Michel Paquot
IPC分类号： A23J3/08 , A23C9/158 , A23C9/12 , A23C9/152 , A23J1/20 , A23C19/09 , A23C21/06 , A21D13/08 , A23C13/12 , A23C9/142 , A61K35/20 , A61P3/10 , A61P35/00
CPC分类号： A23C9/1307 , A21D2/32 , A23C13/12 , A23C19/082 , A23C2240/05
摘要： A milk ingredient is enriched in polar lipids, in particular in phospholipids and in sphingolipids, in which the percentage of phospholipids is greater than 10% by weight, relative to the weight of solids of the ingredient, and a method obtains the same starting from pasteurized cream and is used in food and/or pharmaceutical products.
摘要翻译： 乳成分富含极性脂质，特别是在磷脂和鞘脂中，其中相对于成分的固体重量，磷脂的百分比大于10重量％，并且从巴氏杀菌中获得相同的方法 奶油，用于食品和/或药品。
-
公开(公告)号：US20090232916A1
公开(公告)日：2009-09-17
申请号：US11573457
申请日：2005-08-09
申请人： Avidor Shulman , Dori Pelled , Tzafra Cohen
发明人： Avidor Shulman , Dori Pelled , Tzafra Cohen
IPC分类号： A61K36/16 , A61K31/20 , A61K31/35 , A61K31/397 , A61K31/66
CPC分类号： A23D9/013 , A21D2/02 , A21D2/16 , A21D2/263 , A21D2/266 , A21D2/32 , A21D13/062 , A23C9/13 , A23C9/158 , A23C11/103 , A23C2240/10 , A23G1/32 , A23G1/36 , A23L2/38 , A23L27/60 , A23L33/105 , A23L33/11 , A23L33/12 , A23L33/19 , A23L33/40 , A23V2002/00 , A61K45/06 , A23V2200/328 , A23V2250/5488 , A23V2250/2136 , A23V2250/1852 , A23V2250/2132
摘要： Disclosed is a novel food product characterized by a low glucose or glucose free content, a balanced functional fat content, and a proactive agent aimed for the diabetic and diabetic-prone populations. The food product of the invention is a functional food which may be used clinically to lower the lipid level in people suffering from an imbalanced lipid profile and which may progress towards diabetes complications and coronary vascular disorders. In particular embodiments the proactive agent can be any of a naturally occurring lipid, a synthetic or mimetic lipid which is not digestible by humans and interferes with body weight gain/loss, plant extracts and substances derived therefrom, antioxidants, animal-derived substances, minerals and pharmaceuticals, and any mixture thereof.
摘要翻译： 公开了一种以低葡萄糖或无葡萄糖含量，平衡的功能性脂肪含量为特征的新型食品，以及针对糖尿病和糖尿病易患群体的主动剂。 本发明的食品是一种功能性食品，其可以在临床上用于降低患有不平衡脂质分布的人的脂质水平，并且可能进展为糖尿病并发症和冠状动脉血管疾病。 在具体实施方案中，主动剂可以是天然存在的脂质，合成或模拟的脂质，其不被人消化并干扰体重增加/减少，植物提取物和衍生自其的物质，抗氧化剂，动物衍生物质，矿物质 和药物，以及它们的任何混合物。
-
公开(公告)号：US20080261916A1
公开(公告)日：2008-10-23
申请号：US11917236
申请日：2006-06-12
IPC分类号： A61K31/716 , A61K31/715 , A61P35/00 , A61P15/00 , A61K31/718
CPC分类号： A61Q5/00 , A21D2/14 , A21D2/165 , A21D2/18 , A21D2/181 , A21D2/245 , A21D2/32 , A21D10/002 , A23K20/158 , A23K20/163 , A23K20/168 , A23K20/20 , A23L2/52 , A23L13/426 , A23L33/10 , A23L33/105 , A23L33/11 , A23L33/22 , A23V2002/00 , A61K8/73 , A61K8/732 , A61K8/737 , A61K31/702 , A61Q19/00 , A23V2200/324 , A23V2200/308 , A23V2200/3202 , A23V2250/2136 , A23V2250/194 , A23V2250/1842 , A23V2250/063 , A23V2250/5062 , A23V2250/28 , A23V2250/614 , A23V2250/5034 , A23V2250/2102 , A23V2250/634
摘要： The invention relates to synergistic compositions comprising prebiotic components selected from fructose polymers GFn and Fm, either containing a glucose (G) end-group, or without a glucose end-group, and one or more component of a group of prebiotics consisting of modified or unmodified starch and partial hydrolysates thereof, partially hydrolysed inulin, natural oligofractoses, fructo-oligosaccharides (FOS), lactulose, galactomannan and suitable partial hydrolysates thereof, indigestible polydextrose, acemannan, various gums, indigestible dextrin and partial hydrolysates thereof, trans-galacto-oligosaccharides (GOS), xylo-oligosaccharides (XOS), beta-glucan and partial hydrolysates thereof, together if desired with phytosterol/phytostanol components and their suitable esters, and if desired other plant extracts, mineral components, vitamins and additives.
摘要翻译： 本发明涉及协同组合物，其包含选自果糖聚合物GF N和F m的益生元组分，其含有葡萄糖（G）端基，或不含葡萄糖末端 - 一组由改性或未改性淀粉及其部分水解产物，部分水解的菊粉，天然寡糖，低聚果糖（FOS），乳果糖，半乳甘露聚糖及其合适的部分水解产物组成的益生元组合的一种或多种组分，不可消化的聚葡萄糖，醋甘露聚糖 ，各种口香糖，难消化的糊精和部分水解产物，反式低聚半乳糖（GOS），低聚木糖（XOS），β-葡聚糖及其部分水解产物，如果需要，植物甾醇/植物甾醇成分及其合适的酯类， 所需的其他植物提取物，矿物成分，维生素和添加剂。
-
8.发明申请Glycerophospholipids containing omega-3 and omega-6 fatty acids and their use in the treatment and improvement of cognitive functions 有权含有ω-3和ω-6脂肪酸的甘油磷脂及其在治疗和改善认知功能中的应用公开(公告)号：US20060241080A1
公开(公告)日：2006-10-26
申请号：US11414150
申请日：2006-04-28
申请人： Gai Dror , Dorit Plat , Orly Farkash , Rassan Zuabi , Zohar Bar-On , Avidor Shulman , Dori Pelled
发明人： Gai Dror , Dorit Plat , Orly Farkash , Rassan Zuabi , Zohar Bar-On , Avidor Shulman , Dori Pelled
IPC分类号： A61K31/685 , C07F9/02 , C12P13/00
CPC分类号： A21D2/32 , A23D7/011 , A23D7/013 , A23D9/013 , A23K20/158 , A23L33/12 , A23V2002/00 , A61K31/685 , C07F9/106 , A23V2200/322 , A23V2250/1882 , A23V2250/1942 , A23V2250/1842
摘要： Disclosed herein is a lipid preparation, said preparation comprising a phosphatidylserine moiety, and poly-unsaturated fatty acid (PUFA) acyl groups, particularly long-chain poly-unsaturated fatty acid (LC-PUFA) acyl groups such as omega-3 and/or omega-6 acyl groups, wherein said PUFA is covalently bound to said glycerophospholipid. Said lipid preparations are particularly useful in the treatment of mental and cognitive disorders, e.g. ADHD (attention deficit hyperactivity disorder) and Alzheimer's disease. The disclosed preparations present improved bioactivity, and are useful in the treatment of various cognitive and mental conditions and disorders, as well as for maintenance of normal functions of brain-related systems and processes.
摘要翻译： 本文公开了一种脂质制剂，所述制剂包含磷脂酰丝氨酸部分和多不饱和脂肪酸（PUFA）酰基，特别是长链多不饱和脂肪酸（LC-PUFA）酰基，例如ω-3和/或 ω-6酰基，其中所述PUFA与所述甘油磷脂共价结合。 所述脂质制剂特别可用于治疗精神和认知障碍，例如， ADHD（注意缺陷多动障碍）和阿尔茨海默病。 所公开的制剂提供了改善的生物活性，并且可用于治疗各种认知和精神状况和障碍，以及维持脑相关系统和过程的正常功能。
-
公开(公告)号：US20050130937A1
公开(公告)日：2005-06-16
申请号：US10994175
申请日：2004-11-19
申请人： Gai Ben Dror , Dorit Platt , Orly Farkash , Rassan Zuabi , Zohar Bar-On , Avidor Shulman , Dori Pelled
发明人： Gai Ben Dror , Dorit Platt , Orly Farkash , Rassan Zuabi , Zohar Bar-On , Avidor Shulman , Dori Pelled
CPC分类号： A61K31/685 , A21D2/32 , A23D7/013 , A23D9/013 , A23L33/12 , A23V2002/00 , A23V2200/322 , A23V2250/1882 , A23V2250/1942 , A23V2250/1842
摘要： A lipid preparation including a glycerophospholipid or salt, conjugate and derivatives thereof, particularly phosphatidylserine (PS), phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidyl-inositol (PI), phosphatidylglycerol (PG) and phosphatidic acid (PA), and poly-unsaturated fatty acid (PUFA) acyl groups, particularly long-chain poly-unsaturated fatty acid (LC-PUFA) acyl groups such as omega-3 and/or omega-6 acyl groups, wherein said PUFA is covalently bound to said glycerophospholipid. The preparation possesses an improved bioactivity, and is useful in the treatment of various cognitive and mental conditions and disorders and for maintenance of normal functions of brain-related systems and processes.
摘要翻译： 一种包含甘油磷脂或盐的缀合物及其衍生物，特别是磷脂酰丝氨酸（PS），磷脂酰胆碱（PC），磷脂酰乙醇胺（PE），磷脂酰肌醇（PI），磷脂酰甘油（PG）和磷脂酸（PA） - 不饱和脂肪酸（PUFA）酰基，特别是长链多不饱和脂肪酸（LC-PUFA）酰基如ω-3和/或ω-6酰基，其中所述PUFA与所述甘油磷脂共价结合。 该制剂具有改善的生物活性，并且可用于治疗各种认知和精神状况和障碍，并用于维持脑相关系统和过程的正常功能。
-
公开(公告)号：US5196226A
公开(公告)日：1993-03-23
申请号：US787789
申请日：1991-11-04
申请人： Hiroshi Sakka , Yuzo Ikezoe , Tetsuro Fukuda
发明人： Hiroshi Sakka , Yuzo Ikezoe , Tetsuro Fukuda
IPC分类号： A21D2/02 , A21D2/16 , A21D2/32 , A23L1/00 , A23L1/035 , A23L1/176 , A23L1/19 , B01F17/00 , B01F17/14 , C09K3/00
摘要： A powdery foaming agent suitable for cake and fry batters and premixes therefor, comprising saturated monoglyceride, saturated diglycerine monoester, lecithin and polyphosphate as essential ingredients is disclosed.
摘要翻译： 公开了一种适用于蛋糕和油炸面糊及其预混物的粉状发泡剂，其包含饱和甘油单酯，饱和二甘油单酯，卵磷脂和多磷酸盐作为必要成分。
-
-
-
-
-
-
-
-
-
搜索结果
111 条记录 (耗时 0.03 秒)
